Gangliosides modulate proliferation, migration, and invasiveness of human brain tumor cells in vitro
- 1 February 1995
- journal article
- research article
- Published by Springer Nature in Molecular and Chemical Neuropathology
- Vol. 24 (2-3) , 121-135
- https://doi.org/10.1007/bf02962138
Abstract
Gliomas, the most common form of intrinsic brain tumor, are characterized by diffuse local invasion of the normal brain structures, irrespective of their histological grade of malignancy; a feature that is a major obstacle to successful therapy. They generally infiltrate the central nervous system (CNS) as individual tumor cells several centimeters beyond the macroscopic tumor margin and consequently often recur, after subtotal surgical resection. Factors involved in the control of both their proliferation and invasiveness are poorly documented. In this work, the role of gangliosides on proliferation of both human fetal human brain cells and five cell lines derived from human gliomas with different grades of malignancy was investigated. In addition, 8 μm-porosity polycarbonate filters were used to study cell motility. In addition, these filters were coated with the reconstituted extracellular matrix (ECM) composite, Matrigel, to assess invasiveness. The results presented show that gangliosides generally exert a proliferation inhibitory effect on fetal brain cells and glioma cell lines in vitro and play an important role in promoting glioma cell motility and invasiveness. The molecular mechanisms involved in the action of gangliosides may prove useful in identifying new targets for an anti-invasion therapy.Keywords
This publication has 30 references indexed in Scilit:
- Adhesion of Human Glioma Cell Lines to Fibronectin, Laminin, Vitronectin and Collagen I Is Modulated by Gangliosides in vitroCell Adhesion and Communication, 1995
- Effect of recombinant tumor necrosis factor-α on three-dimensional growth, morphology, and invasiveness of human glioblastoma cells in vitroJournal of Neurosurgery, 1993
- Ganglioside expression on human malignant melanoma assessed by quantitative immune thin‐layer chromatographyInternational Journal of Cancer, 1993
- Nerve Growth Factor Mediates Monosialoganglioside‐Induced Release of Fibronectin and J1/Tenascin from C6 Glioma CellsJournal of Neurochemistry, 1991
- A human glioma cell line retaining expression of GFAP and gangliosides, recognized by A2B5 and LB1 antibodies, after prolonged passageNeuropathology and Applied Neurobiology, 1990
- Ganglioside Inhibition of (125I)-Plasmin Binding to Colorectal Carcinoma CellsJournal of Receptor Research, 1990
- Involvement of gangliosides and glycoprotein fibronectin receptors in cellular adhesion to fibronectinExperimental Cell Research, 1988
- An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in an divalent cation-dependent functional complex with the disialoganglioside GD2.The Journal of cell biology, 1987
- Binding of momoclonal antibody A2B5 to gangliosidesBiochemical and Biophysical Research Communications, 1983
- Pathology of Tumours of the Nervous System (4th edition)The American Journal of Surgical Pathology, 1978